Joinn 昭衍新药
11 significant filings since 29 May 2026: 9 on equity incentive, 1 on dividend and 1 on major holder selling. The latest, on 24 Jul 2026: 昭衍新药2026年A股限制性股票激励计划授予结果公告.
自 29 May 2026 起有 11 份重大公告：equity incentive 9 份、dividend 1 份、major holder selling 1 份。最新一份（24 Jul 2026）：昭衍新药2026年A股限制性股票激励计划授予结果公告。
Price History 价格走势
5 sessions 个交易日, 18 Sep to 24 Sep 2026 · Live one-minute prices · High 最高 ¥49.53 · Low 最低 ¥44.58 · −2.89% on the previous close of ¥47.77| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 2 brokers | 2 brokers |
| 7 days ago | 2 brokers | 2 brokers |
| 30 days ago | 1 broker | 1 broker |
| 60 days ago | 2 brokers | 2 brokers |
| 90 days ago | 2 brokers | 2 brokers |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 1 ▼ 0 = 0 | ▲ 1 ▼ 0 = 0 |
| Last 90 days | ▲ 2 ▼ 0 = 0 | ▲ 2 ▼ 0 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
| Year | Filed | Consensus | Brokers 券商 | Reported 实际 | Surprise 偏差 |
|---|---|---|---|---|---|
| FY2022 | 31 Mar 2023 | 1.98 | 3 | 1.44 | -27.3% |
| FY2021 | 31 Mar 2022 | 1.46 | 3 | 1.08 | -26.0% |
Surprise is reported EPS against the consensus on the day before the annual report was filed. 偏差为实际每股收益与年报披露前一日一致预期之差。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0.